Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I trial evaluating WO-VET-S3

Next Previous
Trial Profile

A phase I trial evaluating WO-VET-S3

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 28 May 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs WO VET S3 (Primary)
  • Indications Cancer
  • Focus Therapeutic Use

Most Recent Events

  • 28 May 2019 New trial record
  • 22 May 2019 According to a Western Oncolytics media release, this trial is expected to start in 2020.
  • 22 May 2019 According to a Western Oncolytics media release, it was awarded a Small Business Innovation Research (SBIR) Grant. SBIR grants are coordinated by the Small Business Administration of the U.S. Government and which will be applied toward advancing the lead clinical candidate, WO-VET-S3, into the clinic.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top